NCT04571879View on ClinicalTrials.gov

Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children

PHASE3UnknownINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 25, 2021

Primary Completion Date

December 30, 2023

Study Completion Date

February 28, 2024

Conditions
Procedural AnxietyProcedural Pain
Interventions
DRUG

Nebulized Lidocaine

Nebulized Lidocaine for Reducing Pain of Nasogastric Tube Insertion in Children

DRUG

Intranasal Midazolam

Intranasal Midazolam for reducing anxiety of Nasogastric Tube insertion

OTHER

Placebo

Nebulized normal saline and intranasal normal sline

Trial Locations (2)

3050

RECRUITING

Pediatric Emergency Center, Hamad Medical Corporation, Doha

NOT_YET_RECRUITING

Sidra Medicine, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY